| Literature DB >> 34671674 |
Ahmad M Eid1, Linda Issa1, Omamah Al-Kharouf1, Raghad Jaber1, Fatima Hreash1.
Abstract
This study is aimed at developing coriander oil into a nanoemulgel and evaluating its antimicrobial and anticancer effects. Coriander (Coriandrum sativum) oil was developed into a nanoemulgel by using a self-nanoemulsifying technique with Tween 80 and Span 80. Hydrogel material (Carbopol 940) was then incorporated into the nanoemulsion and mixed well. After this, we evaluated the particle size, polydispersity index (PDI), rheology, antimicrobial effect, and cytotoxic activity. The nanoemulsion had a PDI of 0.188 and a particle size of 165.72 nm. Interesting results were obtained with the nanoemulgel against different types of bacteria, such as Pseudomonas aeruginosa, Klebsiella pneumoniae, and methicillin-resistant Staphylococcus aureus (MRSA), with a minimum inhibitory concentration (MIC) of 2.3 μg/ml, 3.75 μg/ml, and 6.5 μg/ml, respectively. In addition, the half-maximal inhibitory concentration (IC50) of the nanoemulgel when applying it to human breast cancer cells (MCF-7), hepatocellular carcinoma cells (Hep3B), and human cervical epithelioid carcinoma cells (HeLa) was 28.84 μg/ml, 28.18 μg/ml, and 24.54 μg/ml, respectively, which proves that the nanoemulgel has anticancer effects. The development of C. sativum oil into a nanoemulgel by using a self-nanoemulsifying technique showed a bioactive property better than that in crude oil. Therefore, simple nanotechnology techniques are a promising step in the preparation of pharmaceutical dosage forms.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34671674 PMCID: PMC8523232 DOI: 10.1155/2021/5247816
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Pseudo-ternary phase diagram of C. sativum oil nanoemulsion.
The selected formulation of C. sativum oil nanoemulsion.
| Formulation | Tween 80 (%) | Span 80 (%) |
| Droplet size (nm ± SD) | PDI ± SD |
|---|---|---|---|---|---|
| 1 | 70 | 10 | 20 | 189.59 ± 2.31 | 0.243 ± 0.09 |
| 2 | 60 | 5 | 35 | 167.71 ± 1.82 | 0.177 ± 0.04 |
| 3 | 45 | 5 | 50 | 165.72 ± 1.44 | 0.188 ± 0.07 |
Figure 2The droplet size and polydispersity index (PDI) of C. sativum oil nanoemulgel with different Carbopol concentrations.
Figure 3Zeta potential of C. sativum oil nanoemulgel with different Carbopol concentrations.
Figure 4Rheological behaviour of C. sativum oil nanoemulgel with different Carbopol concentrations.
MIC values (μg/ml ± 0.03) of C. sativum oil and C. sativum oil nanoemulgel compared with ampicillin, ciprofloxacin, and fluconazole antibiotics.
| Microorganisms |
|
| Ampicillin | Ciprofloxacin | Fluconazole |
|---|---|---|---|---|---|
|
| 9 | 8 | 6.25 | 0.78 | — |
| MRSA | 8 | 6.5 | 32 | 12.5 | — |
|
| 5.5 | 5 | 3.12 | 0.78 | — |
|
| 8 | 7 | 3.25 | 0.06 | — |
|
| 5 | 3.75 | 12.5 | 0.06 | — |
|
| 3 | 2.3 | 100 | 3.12 | — |
|
| 6 | 4.5 | — | — | 3.12 |
Figure 5Cytotoxic effects of C. sativum oil and its nanoemulgel compared with doxorubicin.
Figure 6The IC50 values (μg/ml) of C. sativum oil, C. sativum oil nanoemulgel, and doxorubicin against different cancer cell lines.
The IC50 values (μg/ml) of C. sativum oil, C. sativum oil nanoemulgel, and doxorubicin against different cancer cell lines.
| Hep3B | Hela | MCF-7 | |
|---|---|---|---|
|
| 63.09 ± 1.32 | 67.60 ± 1.22 | 36.30 ± 1.17 |
|
| 28.18 ± 0.86 | 24.54 ± 0.95 | 28.84 ± 0.83 |
| Doxorubicin IC50 ( | 21.37 ± 0.62 | 10.11 ± 1.17 | 15.02 ± 0.72 |